1. Home
  2. SLGL vs NSTS Comparison

SLGL vs NSTS Comparison

Compare SLGL & NSTS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SLGL
  • NSTS
  • Stock Information
  • Founded
  • SLGL 1997
  • NSTS 1921
  • Country
  • SLGL Israel
  • NSTS United States
  • Employees
  • SLGL N/A
  • NSTS N/A
  • Industry
  • SLGL Biotechnology: Pharmaceutical Preparations
  • NSTS Savings Institutions
  • Sector
  • SLGL Health Care
  • NSTS Finance
  • Exchange
  • SLGL Nasdaq
  • NSTS Nasdaq
  • Market Cap
  • SLGL 69.1M
  • NSTS 63.0M
  • IPO Year
  • SLGL 2018
  • NSTS N/A
  • Fundamental
  • Price
  • SLGL $26.57
  • NSTS $11.80
  • Analyst Decision
  • SLGL
  • NSTS
  • Analyst Count
  • SLGL 0
  • NSTS 0
  • Target Price
  • SLGL N/A
  • NSTS N/A
  • AVG Volume (30 Days)
  • SLGL 32.9K
  • NSTS 3.7K
  • Earning Date
  • SLGL 11-14-2025
  • NSTS 11-12-2025
  • Dividend Yield
  • SLGL N/A
  • NSTS N/A
  • EPS Growth
  • SLGL N/A
  • NSTS N/A
  • EPS
  • SLGL N/A
  • NSTS N/A
  • Revenue
  • SLGL $23,931,000.00
  • NSTS $9,435,000.00
  • Revenue This Year
  • SLGL N/A
  • NSTS N/A
  • Revenue Next Year
  • SLGL $31.17
  • NSTS N/A
  • P/E Ratio
  • SLGL N/A
  • NSTS N/A
  • Revenue Growth
  • SLGL 264.86
  • NSTS 69.39
  • 52 Week Low
  • SLGL $4.01
  • NSTS $9.50
  • 52 Week High
  • SLGL $30.00
  • NSTS $13.32
  • Technical
  • Relative Strength Index (RSI)
  • SLGL 65.38
  • NSTS 45.90
  • Support Level
  • SLGL $23.15
  • NSTS $11.46
  • Resistance Level
  • SLGL $24.85
  • NSTS $12.00
  • Average True Range (ATR)
  • SLGL 2.32
  • NSTS 0.12
  • MACD
  • SLGL -0.41
  • NSTS -0.01
  • Stochastic Oscillator
  • SLGL 61.43
  • NSTS 62.96

About SLGL Sol-Gel Technologies Ltd.

Sol-Gel Technologies Ltd is a dermatology company. It is engaged in identifying, developing and commercializing branded and generic topical drug products for the treatment of skin diseases. The company's product candidate pipeline includes SGT-610 (Patidegib Gel 2%), a new chemical entity hedgehog signaling pathway blocker, for the chronic use and prevention of new BCC in Gorlin syndrome patients, and the topical drug candidate SGT-210 for the treatment of Darier Disease and other rare keratosis-related indications such as PC, PPK and Olmsted.

About NSTS NSTS Bancorp Inc.

NSTS Bancorp Inc is a savings and loan holding company regulated Federal Reserve Board. The company was formed to serve as the North Shore Trust and Savings stock holding company. The Bank is a wholly-owned subsidiary of the company and operates as a traditional savings institution focused on serving the banking needs of customers in market area of Lake County, Illinois and adjacent communities.

Share on Social Networks: